Paula Fernández-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Paula Fernández-Rodríguez has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
J.M. Jiménez-Hoyuela García
Servicio de Medicina Nuclear, Hospital Universitario Virgen del Rocío, Sevilla, España
5 shared publicationsI. Acevedo Báñez
Servicio de Medicina Nuclear, Hospital Universitario Virgen del Rocío, Sevilla, España
4 shared publicationsIrene Acevedo Báñez
Department of Nuclear Medicine, Virgen del Rocio Universitary Hospital, Seville, Spain
3 shared publicationsJosé Manuel Jiménez-Hoyuela García
Department of Nuclear Medicine, Virgen del Rocío University Hospital, Seville, Spain
3 shared publicationsC. Sánchez Matas
Servicio de Cirugía Cardiovascular, Hospital Universitario Virgen del Rocío, Sevilla, España
2 shared publicationsIsabel Borrego Dorado
Nuclear Medicine
2 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (12) , 7391-7406
Semiquantitative [¹²³I]FP-CIT SPECT metrics combined with machine learning improve clinical differentiation of Parkinson’s disease and atypical parkinsonian syndrome
Purpose: To evaluate whether semiquantitative striatal [¹²³I]FP-CIT SPECT-derived metrics improve clinical differentiation of degenerative parkinsonism using an integrated machine learning approach. Methods: This cross-sectional study included 487 patients with Parkinson’s disease (PD) and 219 with atypical parkinsonisms (APS), classified as progressive supranuclear palsy (PSP, n = 127), multiple system atrophy parkinsonian type (MSA-P, n = 37), multiple system atrophy cerebellar type (MSA-C, n = 12), and corticobasal degeneration (CBD, n = 43). All participants underwent a [¹²³I]FP-CIT SPECT. Striatal [¹²³I]FP-CIT uptake was quantified using anatomical (caudate, putamen, ventral striatum) and functional (limbic, executive, sensorimotor) parcellations to calculate specific binding ratios, asymmetry indices, and inter-regional ratios. Discriminative performance of each metric was evaluated using receiver operating characteristic (ROC) curves analyses. A random forest classifier integrating all semiquantitative metrics was trained and validated, enabling data-driven identification diagnostic pathways. Results: Caudate-to-putamen and sensorimotor-to-limbic inter-regional ratios showed the strongest discriminative performance (AUC up to 0.95) for differentiating PD from APS. The random forest achieved a 64% overall accuracy with high per-class specificities (> 84%) and revealed two diagnostic pathways. A lower caudate-to-posterior putamen ratio, primarily grouped PSP, CBD and MSA-C, where lower contralateral sensorimotor uptake pointing to PSP while higher values and ipsilateral caudate uptake subregion further distinguishing CBD from MSA-C. A higher caudate-to-posterior putamen ratio, included PD and MSA-P, where lower ipsilateral caudate uptake together with a higher sensorimotor-to-cognitive ratio mainly differentiate both groups. Conclusions: Integrating anatomical and functional [¹²³I]FP-CIT SPECT metrics within a machine learning framework enhances the clinical differentiation of degenerative parkinsonisms and supports [¹²³I]FP-CIT SPECT as a robust in vivo disease biomarker.
- 3 July 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (12) , 7391-7406
Open AccessSemiquantitative [¹²³I]FP-CIT SPECT metrics combined with machine learning improve clinical differentiation of Parkinson’s disease and atypical parkinsonian syndrome
Purpose: To evaluate whether semiquantitative striatal [¹²³I]FP-CIT SPECT-derived metrics improve clinical differentiation of degenerative parkinsonism using an integrated machine learning approach. Methods: This cross-sectional study included 487 patients with Parkinson’s disease (PD) and 219 with atypical parkinsonisms (APS), classified as progressive supranuclear palsy (PSP, n = 127), multiple system atrophy parkinsonian type (MSA-P, n = 37), multiple system atrophy cerebellar type (MSA-C, n = 12), and corticobasal degeneration (CBD, n = 43). All participants underwent a [¹²³I]FP-CIT SPECT. Striatal [¹²³I]FP-CIT uptake was quantified using anatomical (caudate, putamen, ventral striatum) and functional (limbic, executive, sensorimotor) parcellations to calculate specific binding ratios, asymmetry indices, and inter-regional ratios. Discriminative performance of each metric was evaluated using receiver operating characteristic (ROC) curves analyses. A random forest classifier integrating all semiquantitative metrics was trained and validated, enabling data-driven identification diagnostic pathways. Results: Caudate-to-putamen and sensorimotor-to-limbic inter-regional ratios showed the strongest discriminative performance (AUC up to 0.95) for differentiating PD from APS. The random forest achieved a 64% overall accuracy with high per-class specificities (> 84%) and revealed two diagnostic pathways. A lower caudate-to-posterior putamen ratio, primarily grouped PSP, CBD and MSA-C, where lower contralateral sensorimotor uptake pointing to PSP while higher values and ipsilateral caudate uptake subregion further distinguishing CBD from MSA-C. A higher caudate-to-posterior putamen ratio, included PD and MSA-P, where lower ipsilateral caudate uptake together with a higher sensorimotor-to-cognitive ratio mainly differentiate both groups. Conclusions: Integrating anatomical and functional [¹²³I]FP-CIT SPECT metrics within a machine learning framework enhances the clinical differentiation of degenerative parkinsonisms and supports [¹²³I]FP-CIT SPECT as a robust in vivo disease biomarker.
- 28 July 2023
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 42 (6) , 420-421
Angiosarcoma epitelioide mediastínico: hallazgos característicos en PET/TC [18F]FDG en un caso infrecuente de un varón joven
- 28 July 2023
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 42 (6) , 420-421
Angiosarcoma epitelioide mediastínico: hallazgos característicos en PET/TC [18F]FDG en un caso infrecuente de un varón joven
- 1 November 2022
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 41 (6) , 391-392
Recidiva precoz detectada por [18F]FDG PET/TC y hallazgos en la fibrobroncoscopia en paciente con metástasis traqueal múltiple de carcinoma de endometrio
- 1 November 2022
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 41 (6) , 391-392
Recidiva precoz detectada por [18F]FDG PET/TC y hallazgos en la fibrobroncoscopia en paciente con metástasis traqueal múltiple de carcinoma de endometrio
- 1 May 2022
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
- Vol. 41 (3) , 188-189
[18F]FDG PET/CT in an azygos vein spindle-cell sarcoma in a patient with thoracic pain
- 1 May 2022
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
- Vol. 41 (3) , 188-189
[18F]FDG PET/CT in an azygos vein spindle-cell sarcoma in a patient with thoracic pain
- 1 May 2022
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 41 (3) , 188-189
18F-FDG PET/TC en un sarcoma fusocelular de la vena ácigos en un paciente con dolor torácico
- 1 May 2022
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 41 (3) , 188-189
18F-FDG PET/TC en un sarcoma fusocelular de la vena ácigos en un paciente con dolor torácico
- 13 January 2021
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 46 (3) , e171-e172
Acute Brain Stroke Evolution Detected by 18F-FDG PET/CT and MRI Justifies the Discordance of Lesions in a Patient With Lymphoproliferative Syndrome
A 50-year-old man with angioimmunoblastic T-cell lymphoma in complete response to treatment presented new hypermetabolic brain lesions on 18F-FDG PET/CT suggestive of malignancy. These findings were correlated by MRI that showed cortical-subcortical peripheral lesions typical of acute ischemic infarction. A restaging 18F-FDG PET/CT showed that hypermetabolic lesions were replaced by ametabolic areas, supporting chronic infarction. Early ischemia presents transitory FDG increase. Brain lymphomas are highly FDG avid and difficult to differentiate from acute cerebral infarction. In view of the discordance of abnormal areas of intracranial uptake on PET FDG, MRI confirmation is required to avoid misinterpretation.
- 13 January 2021
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 46 (3) , e171-e172
Acute Brain Stroke Evolution Detected by 18F-FDG PET/CT and MRI Justifies the Discordance of Lesions in a Patient With Lymphoproliferative Syndrome
A 50-year-old man with angioimmunoblastic T-cell lymphoma in complete response to treatment presented new hypermetabolic brain lesions on 18F-FDG PET/CT suggestive of malignancy. These findings were correlated by MRI that showed cortical-subcortical peripheral lesions typical of acute ischemic infarction. A restaging 18F-FDG PET/CT showed that hypermetabolic lesions were replaced by ametabolic areas, supporting chronic infarction. Early ischemia presents transitory FDG increase. Brain lymphomas are highly FDG avid and difficult to differentiate from acute cerebral infarction. In view of the discordance of abnormal areas of intracranial uptake on PET FDG, MRI confirmation is required to avoid misinterpretation.
- Open Access
- 1 June 2020
- Published by Elsevier in eNeurologicalSci
- Vol. 19, 100240
Differential diagnosis of HaNDL syndrome in a case report of a pediatric patient: The role of SPECT with 99mTc-HMPAO
- 1 June 2020
- Published by Elsevier in eNeurologicalSci
- Vol. 19, 100240
Open AccessDifferential diagnosis of HaNDL syndrome in a case report of a pediatric patient: The role of SPECT with 99mTc-HMPAO
- 1 October 2019
- Published by Elsevier in Digestive and Liver Disease
- Vol. 51 (10) , 1485
Sclerosing mesenteritis by Mycobacterium Genavense mimicking a lymphoproliferative syndrome: The value of 18F-FDG PET/CT
- 1 October 2019
- Published by Elsevier in Digestive and Liver Disease
- Vol. 51 (10) , 1485
Sclerosing mesenteritis by Mycobacterium Genavense mimicking a lymphoproliferative syndrome: The value of 18F-FDG PET/CT
- 7 September 2019
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 47 (1) , 222-223
18F-FDG PET/CT in lung B lymphoid hyperplasia-type Castleman disease
We present a 62-year-old woman who, after a catarrhal episode, underwent a chest xray and a chest CT, identifying a pleural-based mass in the left lower lobe. This lesion presented a mixed pattern with solid and peripheral ground-glass attenuation, and an air-bronchogram sign. Despite de suspicion of bronchopneumonia, a lung neoplasm like a predominantly lepidic adenocarcinoma could not be ruled. A 18 F-FDG PET/CT showed a focal radiotracer uptake with SUVmax of 5.34 in the pulmonary lesion, supporting the neoplastic etiology. Consequently, a lower lobectomy was performed and histological examination concluded that the final diagnosis was a B lymphoid hyperplasia-type Castleman disease. Castleman’s disease is an uncommon disorder that can be easily misdiagnosed as lymphoma, neoplasm or infection. Unicentric Castleman’s disease (UCD) usually presents a hyaline-vascular histological subtype and is usually asymptomatic. Extranodal involvement is very rare. Only a few cases of solid organ involvement such us spleen or parotid gland have been described. UCD originating in the lung is extremely rare and should be considered in the differential diagnosis of a primary pulmonary malignant tumor.
- 7 September 2019
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 47 (1) , 222-223
18F-FDG PET/CT in lung B lymphoid hyperplasia-type Castleman disease
We present a 62-year-old woman who, after a catarrhal episode, underwent a chest xray and a chest CT, identifying a pleural-based mass in the left lower lobe. This lesion presented a mixed pattern with solid and peripheral ground-glass attenuation, and an air-bronchogram sign. Despite de suspicion of bronchopneumonia, a lung neoplasm like a predominantly lepidic adenocarcinoma could not be ruled. A 18 F-FDG PET/CT showed a focal radiotracer uptake with SUVmax of 5.34 in the pulmonary lesion, supporting the neoplastic etiology. Consequently, a lower lobectomy was performed and histological examination concluded that the final diagnosis was a B lymphoid hyperplasia-type Castleman disease. Castleman’s disease is an uncommon disorder that can be easily misdiagnosed as lymphoma, neoplasm or infection. Unicentric Castleman’s disease (UCD) usually presents a hyaline-vascular histological subtype and is usually asymptomatic. Extranodal involvement is very rare. Only a few cases of solid organ involvement such us spleen or parotid gland have been described. UCD originating in the lung is extremely rare and should be considered in the differential diagnosis of a primary pulmonary malignant tumor.